Xianling Wang

Xianling Wang

Auto-generated profile, based on publicly available information

Xianling Wang

Department of Neurology and Neurobiology Xuanwu Hospital of Capital Medical University Beijing China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
XWXianling Wang
Xianling Wang
XLXu-Ying Li
Xu-Ying Li
YPYueshan Piao
Yueshan Piao
GYGuobin Yuan
Guobin Yuan
YLYicong Lin
Yicong Lin
CWChaodong Wang
Chaodong Wang

1 May 2021 in Neuroscience Letters
Verified
Journal Article
Open access
ZWZhanjun Wang
Zhanjun Wang
YSYang Song
Yang Song
XWXianling Wang
Xianling Wang
XLXu-Ying Li
Xu-Ying Li
FXFanxi Xu
Fanxi Xu
CWChaodong Wang
Chaodong Wang
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a rare hereditary disease characterized by cerebellar ataxia, pyramidal signs in lower limbs, and sensorimotor neuropathy. The disease is caused by bi-allelic mutations of the SACS gene encoding the sacsin protein. Over 200 mutations have been reported worldwide. Here, we report two unrelated Chinese ARSACS patients with novel mutations revealed by whole-exome sequencing (WES). One 36-year-old female patient exhibited classical ARSACS characteristics including cerebellar ataxia, pyramidal tract signs in the lower limbs and sensorimotor neuropathy, while the other 9-year-old male showed cerebellar ataxia and peripheral neuropathy. WES identified a compound heterozygous variant in the SACS gene (c.5692 G > T, p.E1898X; c.12673-12677 del TATCA, p.Y4225D fs*6) in the female patient and another compound heterozygous variant (c.1773C > A, p.S578X; c.8088-8089 in. CA, p.M2697Q fs*43) in the male patient. All of these novel mutations were predicted to be loss-of-function which affect the expression of the two important C-terminal domains (DnaJ and HEPN). These findings add new insights into the mutational and clinical spectrum of ARSACS.

24 July 2023 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
LZLiping Zhang
Liping Zhang
XLXu-Ying Li
Xu-Ying Li
FXFanxi Xu
Fanxi Xu
LGLehong Gao
Lehong Gao
ZWZhanjun Wang
Zhanjun Wang
TDThe Xuanwu Molecular Counselling Group for Neurogenetic Diseases
The Xuanwu Molecular Counselling Group for Neurogenetic Diseases
Background: Epilepsy (EP) is a common neurological disease in which 70–80% are thought to have a genetic cause. In patients with epilepsy, neurodevelopmental delay (NDD) was prevalent. Next generation of sequencing has been widely used in diagnosing EP/NDD. However, the diagnostic yield remains to be 40%–50%. Many reanalysis pipelines and software have been developed for automated reanalysis and decision making for the diseases. Nevertheless, it is a highly challenging task for smaller genetic centers or a routine pediatric practice. To address the clinical and genetic “diagnostic odyssey,” we organized a Multidisciplinary Molecular Consultation (MMC) team for molecular consultation for 202 children with EP/NDD patients referred by lower level hospitals.Methods: All the patients had undergone an aligned and sequential consultations and discussions by a “triple reanalysis” procedure by clinical, genetic specialists, and researchers.Results: Among the 202 cases for MMC, we totally identified 47 cases (23%) harboring causative variants in 24 genes and 15 chromosomal regions after the MMC. In the 15 cases with positive CNVs, 3 cases harbor the deletions or duplications in 16p11.2, and 2 cases for 1p36. The bioinformatical reanalysis revealed 47 positive cases, in which 12 (26%) were reported to be negative, VUS or incorrectly positive in pre‐MMC reports. Additionally, among 87 cases with negative cases, 4 (5%) were reported to be positive in pre‐MMC reports.Conclusion: We established a workflow allowing for a “one‐stop” collaborative assessments by experts of multiple fields and helps for correct the diagnosis of cases with falsenegative and −positive and VUS genetic reports and may have significant influences for intervention, prevention and genetic counseling of pediatric epilepsy and neurodevelopmental disorders.

26 July 2024 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
YDYue Dong
Yue Dong
MJMilan Jia
Milan Jia
STShuang Tan
Shuang Tan
XLXu-Ying Li
Xu-Ying Li
YSYang Song
Yang Song
CWChaodong Wang
Chaodong Wang